ID   STR-I-189-FRAXA
AC   CVCL_C084
SY   STR-189-FRAXA; INSERMe005-A; INSRMe005-A
DR   hPSCreg; INSRMe005-A
DR   ISCR; 1263
DR   SKIP; SKIP002319
DR   Wikidata; Q54970610
RX   PubMed=20217271;
RX   PubMed=27690107;
WW   https://www.agence-biomedecine.fr/IMG/pdf/inserm_str_i_189_fraxa.pdf
CC   From: INSERM; Paris; France.
CC   Registration: French Agence de la Biomedecine; FE08-065-L1.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C84717; Fragile X syndrome
DI   ORDO; Orphanet_908; Fragile X syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 14
//
RX   PubMed=20217271; DOI=10.1007/s11626-010-9300-8;
RA   Tropel P., Tournois J., Come J., Varela C., Moutou C., Fragner P.,
RA   Cailleret M., Laabi Y., Peschanski M., Viville S.;
RT   "High-efficiency derivation of human embryonic stem cell lines
RT   following pre-implantation genetic diagnosis.";
RL   In Vitro Cell. Dev. Biol. Anim. 46:376-385(2010).
//
RX   PubMed=27690107; DOI=10.3390/genes7100077;
RA   Mor-Shaked H., Eiges R.;
RT   "Modeling fragile X syndrome using human pluripotent stem cells.";
RL   Genes (Basel) 7:77.1-77.19(2016).
//